Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sara Mangialaio"'
Autor:
Paul Ratner, Charles P. Andrews, Frank C. Hampel, Bruce Martin, Dale E. Mohar, Denis Bourrelly, Parisa Danaietash, Sara Mangialaio, Jasper Dingemanse, Abdel Hmissi, Jay van Bavel
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 13, Iss 1, Pp 1-15 (2017)
Abstract Background Antagonism of chemoattractant receptor-homologous molecule on T-helper type-2 cells (CRTH2), a G-protein coupled receptor for prostaglandin D2, could be beneficial for treating allergic disorders. We present findings on the effica
Externí odkaz:
https://doaj.org/article/b297a392d8cc454b985ce9eee666b260
Autor:
Eva, Tiecke, Maurizio, Rainisio, Theodor, Guentert, Stephan, Müller, Liat, Hochman, Eli, Kaplan, Sara, Mangialaio
Publikováno v:
Clinical Pharmacology in Drug Development. 11:1012-1027
Painful diabetic peripheral neuropathy is characterized by burning, stabbing, or electric shock-type pain, which severely impacts day-to-day functioning and quality of life. Here, we report the results of 3 phase I studies with NRD135S.E1 (referred t
Autor:
Eva Tiecke, Maurizio Rainisio, Elon Eisenberg, Julio Wainstein, Eli Kaplan, Michal Silverberg, Liat Hochman, Sara Mangialaio
Publikováno v:
European journal of pain (London, England). 26(8)
Painful diabetic peripheral neuropathy (PDPN) affects up to 26% of patients with diabetes mellitus, with major impacts on their general health and well-being. Most available drugs fail to deliver acceptable pain reduction in the majority of patients
Autor:
Dale Mohar, Bruce G. Martin, Denis Bourrelly, Charles P. Andrews, Frank C. Hampel, Jay van Bavel, Paul H. Ratner, Sara Mangialaio, Parisa Danaietash, Abdel Hmissi, Jasper Dingemanse
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 13, Iss 1, Pp 1-15 (2017)
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Background Antagonism of chemoattractant receptor-homologous molecule on T-helper type-2 cells (CRTH2), a G-protein coupled receptor for prostaglandin D2, could be beneficial for treating allergic disorders. We present findings on the efficacy and sa
Autor:
Abdel Hmissi, Jan Hedner, Sara Mangialaio, Göran Hajak, Olli Polo, Ouali Berkani, Jed Black, Giora Pillar, Gary Zammit
Publikováno v:
Sleep medicine. 36
The orally active dual OXProspective, randomized, double-blind, placebo-controlled, active referenced trial in male and female adults aged 18-64 years with chronic, primary insomnia. Patients were randomized 1:1:1:1 to receive placebo, almorexant 100
Autor:
Christophe Zickler, Sara Mangialaio, Paul Hasler, Teresa Urbanowska, Francois Legay, Sirinda Cheevapruk, Stephan Regenass
Publikováno v:
Journal of Immunological Methods. 316:1-7
Many biomarkers are currently used to monitor patients in clinical studies. Technologies which evaluate, validate and monitor biomarkers in a cost effective and efficient manner are a necessity. Here we describe the development, validation and implem
Publikováno v:
Cell Biology and Toxicology. 19:189-202
Most biological processes are mediated by complex networks of molecular interactions involving proteins. The analysis of protein expression in biological samples is especially important in the identification and monitoring of biomarkers for disease p
Autor:
Valerie Kouskoff, Sara Mangialaio, Diane Mathis, Christophe Benoist, Anne-Sophie Korganow, Hong Ji
Publikováno v:
Arthritis & Rheumatism. 42:2517-2523
Objective. Spontaneous arthritis in the KRN transgenic mouse model is due to the autoreactivity of the transgenic T cell receptor (TCR) against A g7 major histocompatibility complex (MHC) molecules, which leads to strong but incomplete clonal deletio
Autor:
Martina Mirlacher, Juha Kononen, Peter Schraml, Philip Went, Stephan Dirnhofer, Marcel Bundi, Sasa Dimitrijevic, Alessandro Lugli, Guido Sauter, Ronald Simon, Sara Mangialaio
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(22)
Purpose KIT is a target for imatinib mesylate (Gleevec; Novartis Pharma, Basel, Switzerland). Gastrointestinal stromal tumors (GISTs) express KIT and respond favorably to imatinib therapy. To determine other tumors in which such a molecular targeted
Autor:
Hong Ji, Anne-Sophie Korganow, Sara Mangialaio, Petter Höglund, Laurent Poirot, Diane Mathis, Isabelle André, Christophe Benoist, Fred Lühder, Antonio Gonzalez
Publikováno v:
Immunological Reviews
Immunological Reviews, 1999, 169, pp.139-146. ⟨10.1111/j.1600-065x.1999.tb01312.x⟩
Immunological Reviews, 1999, 169, pp.139-146. ⟨10.1111/j.1600-065x.1999.tb01312.x⟩
International audience; T lymphocytes constantly flirt with reactivity to self peptides, a price they pay for their ability to recognize foreign peptides presented by self-MHC molecules, and autoreactivity in the T compartment occasionally gives rise